Synthorx
AcquiredSynthorx is a biotech company in San Diego, United States, founded in 2014. It has raised $79.0M across 3 rounds, most recently a $63.0M Series C in April 2018.
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- synthorx.com
- Total Funding
- $79.0M
- Last Round
- $63.0M Series CApr 2018
- Rounds
- 3
- Acquired by
- SanofiDec 2019 · $2.5B
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.
About
Synthorx was a La Jolla, California biotechnology company that used synthetic biology and a proprietary expanded DNA alphabet — an engineered base pair beyond the natural A, T, G, and C — to discover and develop novel protein therapeutics, diagnostics, and vaccines. Founded on research from Dr. Floyd Romesberg's lab at The Scripps Research Institute, the company was acquired by Sanofi in December 2019 for $2.5 billion.
Summary
It lists 11–50 employees. It has raised $79.0M in total across 3 rounds, most recently a $63.0M Series C round in Apr 2018. Investors include Avalon Ventures, Sanofi Ventures and OrbiMed.
Funding & Exit History
Dec 2019
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synthorx"><img src="https://indexed.vc/api/badge/company/synthorx" alt="Synthorx on Indexed.vc" width="260" height="76" /></a>